Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesReceivablesReceivables - AccuredRetained EarningsSecurities - Mortgage Backed SecuritiesSecurities - TradableShareholder's EquityShares OutstandingShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Global Indemnity (GBLI) Cash & Equivalents (2016 - 2025)

Global Indemnity (GBLI) has 15 years of Cash & Equivalents data on record, last reported at $31.0 million in Q3 2024.

  • For Q3 2024, Cash & Equivalents fell 33.25% year-over-year to $31.0 million; the TTM value through Sep 2024 reached $31.0 million, down 33.25%, while the annual FY2023 figure was $38.0 million, 2.08% down from the prior year.
  • Cash & Equivalents reached $31.0 million in Q3 2024 per GBLI's latest filing, down from $46.7 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $157.9 million in Q1 2022 and bottomed at $18.9 million in Q3 2022.
  • Average Cash & Equivalents over 5 years is $52.2 million, with a median of $45.4 million recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: surged 232.66% in 2022, then tumbled 77.37% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $37.2 million in 2020, then soared by 110.36% to $78.3 million in 2021, then crashed by 50.37% to $38.8 million in 2022, then decreased by 2.08% to $38.0 million in 2023, then dropped by 18.45% to $31.0 million in 2024.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $31.0 million in Q3 2024, $46.7 million in Q2 2024, and $38.9 million in Q1 2024.